跳至主要内容
临床试验/NCT06281080
NCT06281080招募中不适用

First-in-Human Trial of a Novel Endoluminal Robotic System for En-Bloc Resection of Bladder Tumours

Chinese University of Hong Kong2 个研究点 分布在 1 个国家目标入组 10 人开始时间: 2024年11月20日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
10
试验地点
2
主要终点
Successful en-bloc tumour resection by the robotic system

研究概览

简要总结

This is a prospective, single-arm study to evaluate the feasibility and safety of performing transurethral en-bloc resection of bladder tumours using the Zenith robotic system.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age between 18 and 75 years
  • Body mass index <35 kg/m2
  • Bladder tumour located <3 cm in size; clinically non-muscle invasive bladder tumour
  • Clinically indicated for en-bloc resection.
  • Willingness to participate as demonstrated by giving informed consent

排除标准

  • Presence of endoscopic or imaging signs of detrusor muscle invasion
  • Contraindication to general anaesthesia / spinal anaesthesia
  • ASA > 2 patients
  • Severe concomitant illness that drastically shortens life expectancy or increases risk of therapeutic intervention
  • Untreated active infection
  • Un-corrected coagulopathy
  • Presence of another malignancy or distant metastasis
  • Emergency surgery
  • Vulnerable population (e.g. mentally disabled, pregnant)

结局指标

主要结局

Successful en-bloc tumour resection by the robotic system

时间窗: During the operation

The number of cases completed the intervention by robotic system

次要结局

  • Dissection time and speed(During operation)
  • Total procedure time(During operation)
  • Surgeon Console time(During operation)
  • Presence of detrusor muscle in specimen(During operation)
  • Resection Margin(During operation)
  • Intra-operative bladder perforation event(During operation)
  • Post-operative complications(Within 90 days after the study intervention)
  • Need of bladder irrigation(Within 30 days after the study intervention.)
  • Residual tumour or upstaging of tumour after second look TURBT(Within 30 days after the study intervention.)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Chi Fai NG

Professor

Chinese University of Hong Kong

研究点 (2)

Loading locations...

相似试验

First-in-Human Trial of a Novel Endoluminal Robotic... | 临床试验